Clinical development and healthcare is on the verge of a major transformation due to the introduction of newer technologies and research opportunities specifically for biomarkers detection and discovery. Biomarkers have become a focal point of interest in healthcare due to their potential in personalizing and improving medical care.
Biomarkers play a crucial role in identifying diseases at their earliest stages, often before symptoms appear. Early detection can aid in more helpful interventions and better outcomes in patients. HealthCare providers can diagnose diseases or predict
disease risks, Monitor healthy individuals to detect early signs of disease and also
determine the effectiveness of the treatments.
To give an example, troponin, a biomarker, whose elevated levels can indicate myocardial damage. Hemoglobin A1c (HbA1c), reflects the average blood glucose levels of patients over 2-3 months can be used for monitoring and diagnosis of diabetes.
The global biomarkers market was estimated at USD 81.04 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 13.36% from 2024 to 2030. This substantial growth reflects the increasing importance and applications of biomarkers in various areas of healthcare. Biomarkers for cancer, Immunological diseases top the charts when it comes to diseases of focus. There is a growing trend for digital biomarkers, where the data comes from wearables such smart watches and fitness trackers. Digital biomarkers has the ability to create a breakthrough in healthcare sector because of its ability to continuously track and report data. AI can play a huge role in monitoring and detecting biomarkers. Imagine, an AI system that has been trained on data of millions of smart watch users and it can be on the look out for potential biomarkers. The advent of AI provides this utility. If at all a biomarker is noted in a particular user, the user can immediately, doctors can take the necessary steps.
As much as biomarker detection is important, it is also paramount to use AI for biomarker discovery. The process of discovering biomarkers is quite exhaustive and requires lots of resources. But as AI is getting affordable day by day, extensive use of a
sophisticated AI approach is very much on the cards.
AI can analyze multi-omics data (proteomics, genomics), millions of medical records and can indetify the subtle patterns, automate data analysis. AI can leveraged beyond comprehension and can definitely a researcher or a doctor’s best friend in the coming years. Researchers around the world are focused on inventing new ways to identify
biomarkers. The progression of research has never been this fast.
Major players in the biomarkers market, including Abbott, Merck & Co., Johnson & Johnson, Thermo Fisher Scientific, and Bio-Rad Laboratories, are actively investing inp
biomarker research and development. Now is the time to enter into this space.
Good AI has been pioneers in developing platforms for biomarker discovery and detection. We work closely with multiple healthcare companies and research institutes. Good AI’s platform is a one stop for all purposes. The platform uses AI in a ethical and mindful way. If you're interested in exploring how we can work together to drive sustainable innovation through AI, we invite you to contact us. Together, we can create
impactful solutions that benefit both your organization and our planet.
"Ready to drive innovation together? Contact us to explore how our AI solutions can create meaningful impact—empowering your organization and advancing the future for mankind."